Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX)

Historical Holders from Q3 2020 to Q2 2025

Symbol
PSTX on Nasdaq
CUSIP
73730P108
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
98.4M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$308K 0
2025 Q1 100K $308K -$513M $3.08 1
2024 Q4 54M $518M +$17M $9.60 114
2024 Q3 53.5M $153M +$890K $2.86 96
2024 Q2 52.9M $155M -$128K $2.92 90
2024 Q1 52.7M $168M +$23.9M $3.19 90
2023 Q4 81.8K $275K +$144K $3.36 2
2023 Q3 45.2M $108M +$2.94M $2.38 84
2023 Q2 44.5M $78.2M -$5.62M $1.76 90
2023 Q1 44.1M $136M +$3.13M $3.08 99
2022 Q4 42.6M $226M +$18.4M $5.30 87
2022 Q3 38.6M $136M +$59.2M $3.53 63
2022 Q2 21.3M $55M -$1.88M $2.58 48
2022 Q1 24.2M $108M -$13.6M $4.48 60
2021 Q4 26.2M $178M -$953K $6.81 58
2021 Q3 26.1M $190M -$17.1M $7.29 66
2021 Q2 27.9M $279M -$10.7M $10.02 72
2021 Q1 28.9M $276M +$21.6M $9.55 60
2020 Q4 26.3M $288M +$15.2M $10.97 55
2020 Q3 24.5M $212M +$212M $8.87 50